Saint Kitts and Nevis Vaccine Industry Outlook 2024 - 2028

See how Saint Kitts and Nevis Vaccine performed compared to key markets.

Key Market Indicators

Kittitian vaccination coverage for children aged one is projected to remain steady at 96% by 2028, mirroring the current rate in 2023. This statistic reflects no change in average vaccination rates over the five-year period. Historical data reveals that since 1985, the Kittitian market has experienced a slight annual decline of 0.2 percentage points. In terms of vaccine imports, Kittitian expenditures are expected to rise modestly. By 2028, vaccine imports are projected to reach approximately $32,800, up from $31,900 in 2023. This represents an average annual growth rate of 0.3%. Since 1998, the demand for vaccines in Kittitian has seen a gradual increase, averaging a 0.5% annual rise.

Saint Kitts and Nevis Vaccine Market Data and Forecasts

How much will Saint Kitts and Nevis Vaccine Market grow to 2028?

Forecast: Import of Vaccines for Human Use to Saint Kitts and Nevis
Forecast: Polio Vaccine Third Dose (Pol3) Immunization Coverage in Saint Kitts and Nevis
Forecast: Measles-Containing-Vaccine Second-Dose (MCV2) Immunization Coverage in Saint Kitts and Nevis
Forecast: Baccille Calmette Guérin Vaccine (BCG) Immunization Coverage in Saint Kitts and Nevis

Other Top Countries about Vaccine